Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
DTIL — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

6.15

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.27

EPS Last/This Y

1.39

EPS This/Next Y

0.26

Price

7.23

Target Price

32

Analyst Recom

1

Performance Q

83.04

Upside

-1,232.0%

Beta

1.32

Ticker: DTIL




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23DTIL7.310.077.671053
2026-04-24DTIL7.050.1010.001076
2026-04-27DTIL7.040.1010.001076
2026-04-28DTIL7.110.120.001103
2026-04-29DTIL6.870.120.001103
2026-04-30DTIL7.160.121.001104
2026-05-01DTIL7.280.120.001106
2026-05-04DTIL7.660.120.001109
2026-05-05DTIL7.450.120.001113
2026-05-06DTIL7.570.120.001113
2026-05-07DTIL7.470.120.021115
2026-05-08DTIL7.650.121.751158
2026-05-11DTIL7.860.130.061178
2026-05-12DTIL8.220.130.081211
2026-05-13DTIL8.340.130.251234
2026-05-14DTIL8.080.130.271239
2026-05-15DTIL7.260.130.151232
2026-05-18DTIL6.960.070.00392
2026-05-19DTIL6.890.060.00410
2026-05-20DTIL7.160.060.01412
2026-05-21DTIL7.140.05999.99571
2026-05-22DTIL7.210.050.00571
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23DTIL7.3363.8- -3.53
2026-04-24DTIL7.0663.4- -3.16
2026-04-27DTIL7.0663.4- -3.16
2026-04-28DTIL7.1163.4- -3.16
2026-04-29DTIL6.8963.4- -3.16
2026-04-30DTIL7.1663.4- -3.16
2026-05-01DTIL7.2863.4- -3.16
2026-05-04DTIL7.6463.4- -3.16
2026-05-05DTIL7.4663.4- -3.16
2026-05-06DTIL7.5763.4- -3.16
2026-05-07DTIL7.5063.4- -3.16
2026-05-08DTIL7.6763.4- -3.18
2026-05-11DTIL7.8454.0- -3.18
2026-05-12DTIL8.1854.0- -3.18
2026-05-13DTIL8.3654.0- -3.18
2026-05-14DTIL8.0854.0- -3.18
2026-05-15DTIL7.2954.0- -2.17
2026-05-18DTIL6.9371.8- -2.17
2026-05-19DTIL6.9071.8- -2.17
2026-05-20DTIL7.1671.8- -2.17
2026-05-21DTIL7.1671.8- -2.17
2026-05-22DTIL7.2371.8- -2.17
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23DTIL-1.8438.265.09
2026-04-24DTIL-3.6738.265.09
2026-04-27DTIL-3.6738.265.42
2026-04-28DTIL-3.6738.265.42
2026-04-29DTIL-3.6738.265.42
2026-04-30DTIL-3.6638.265.42
2026-05-01DTIL-3.6638.265.42
2026-05-04DTIL-3.6623.445.42
2026-05-05DTIL-3.4923.445.42
2026-05-06DTIL-3.4923.445.42
2026-05-07DTIL-3.4923.445.42
2026-05-08DTIL-3.4923.445.42
2026-05-11DTIL-3.4923.685.42
2026-05-12DTIL-3.4923.686.15
2026-05-13DTIL-3.4923.686.15
2026-05-14DTIL-3.4923.686.15
2026-05-15DTIL-3.4923.686.15
2026-05-18DTIL-3.4923.326.15
2026-05-19DTIL-3.4923.326.15
2026-05-20DTIL-3.4923.326.15
2026-05-21DTIL-3.4923.326.15
2026-05-22DTIL-3.4923.326.15
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.34

Avg. EPS Est. Current Quarter

-0.6

Avg. EPS Est. Next Quarter

-0.61

Insider Transactions

-3.49

Institutional Transactions

23.32

Beta

1.32

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

29

Growth Score

29

Sentiment Score

7

Actual DrawDown %

98.3

Max Drawdown 5-Year %

-99.2

Target Price

32

P/E

Forward P/E

PEG

P/S

4.14

P/B

2.45

P/Free Cash Flow

EPS

-3.72

Average EPS Est. Cur. Y​

-2.17

EPS Next Y. (Est.)

-1.91

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-98.7

Relative Volume

0.66

Return on Equity vs Sector %

-83

Return on Equity vs Industry %

-67.3

EPS 1 7Days Diff

1

EPS 1 30Days Diff

1.36

EBIT Estimation

DTIL Healthcare
$7.23
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
10/20
Pullback
19/25
Volume
9/15
Valuation
9/20
TP/AR
2/10
Options
8/10
RSI
49.7
Range 1M
35.2%
Sup Dist
4.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
41 /100
WEAK
Momentum
7/25
Growth
19/30
Estimates
0/20
Inst/Vol
9/15
Options
6/10
EPS Yr
26.3%
EPS NY
7.6%
52W%
70%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +342.6% upside
Quality
7/30
Valuation
16/30
Growth
13/25
Stability
7/10
LT Trend
3/5
Upside
+342.6%
Quality
29
Precision BioSciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 66
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
DTIL

Latest News

Caricamento notizie per DTIL
stock quote shares DTIL – Precision BioSciences Inc. Stock Price stock today
news today DTIL – Precision BioSciences Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading